As of April 16, 2025, Alcon (ALC) has a market cap of $45.22 billion USD. According to our data, Alcon is ranked No.437 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $45.22 B |
7.70%
|
Dec 31, 2024 | $41.99 B |
9.02%
|
Dec 29, 2023 | $38.51 B |
14.32%
|
Dec 30, 2022 | $33.69 B |
-21.09%
|
Dec 31, 2021 | $42.69 B |
32.23%
|
Dec 31, 2020 | $32.28 B |
16.63%
|
Dec 31, 2019 | $27.68 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Bausch Health
BHC
|
$1.67 B |
-0.000 M
|
![]() Canada
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Abbott Laboratories
ABT
|
$218.91 B |
-0.002 M
|
![]() USA
|
![]() Medtronic
MDT
|
$105.64 B |
0.002 M
|
![]() Ireland
|
![]() Stryker Corporation
SYK
|
$132.37 B |
-0.002 M
|
![]() USA
|
![]() Glaukos
GKOS
|
$5.35 B |
0.000 M
|
![]() USA
|
![]() STAAR Surgical
STAA
|
$0.81 B |
-0.000 M
|
![]() USA
|
![]() Cooper Companies
COO
|
$15.56 B |
-0.001 M
|
![]() USA
|
![]() Becton Dickinson
BDX
|
$58.01 B |
-0.001 M
|
![]() USA
|
![]() Boston Scientific
BSX
|
$139.37 B |
0.007 M
|
![]() USA
|
Market Cap | = | ALC Stock Price | * | ALC Shares Outstanding |
= | $91.42 | * | 0.49 B | |
= | $45.22 B |